219 related articles for article (PubMed ID: 16263298)
21. Anti-HIV-1 protease activity of lanostane triterpenes from the vietnamese mushroom Ganoderma colossum.
El Dine RS; El Halawany AM; Ma CM; Hattori M
J Nat Prod; 2008 Jun; 71(6):1022-6. PubMed ID: 18547117
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity.
Wei Y; Ma CM; Hattori M
Eur J Med Chem; 2009 Oct; 44(10):4112-20. PubMed ID: 19493591
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease.
Min BS; Jung HJ; Lee JS; Kim YH; Bok SH; Ma CM; Nakamura N; Hattori M; Bae K
Planta Med; 1999 May; 65(4):374-5. PubMed ID: 10364847
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide inhibitory substances from the rhizomes of Dioscorea membranacea.
Tewtrakul S; Itharat A
J Ethnopharmacol; 2007 Feb; 109(3):412-6. PubMed ID: 16979312
[TBL] [Abstract][Full Text] [Related]
25. Active constituents against HIV-1 protease from Garcinia mangostana.
Chen SX; Wan M; Loh BN
Planta Med; 1996 Aug; 62(4):381-2. PubMed ID: 8792678
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease.
Hussein G; Miyashiro H; Nakamura N; Hattori M; Kawahata T; Otake T; Kakiuchi N; Shimotohno K
Phytother Res; 1999 Feb; 13(1):31-6. PubMed ID: 10189947
[TBL] [Abstract][Full Text] [Related]
27. Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.
Whiting M; Tripp JC; Lin YC; Lindstrom W; Olson AJ; Elder JH; Sharpless KB; Fokin VV
J Med Chem; 2006 Dec; 49(26):7697-710. PubMed ID: 17181152
[TBL] [Abstract][Full Text] [Related]
28. A bioactive isoprenylated xanthone and other constituents of Garcinia edulis.
Magadula JJ
Fitoterapia; 2010 Jul; 81(5):420-3. PubMed ID: 20006684
[TBL] [Abstract][Full Text] [Related]
29. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes.
Rezácová P; Pokorná J; Brynda J; Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezác J; Grantz Sasková K; Sieglová I; Plesek J; Sícha V; Grüner B; Oberwinkler H; Sedlácek' J; Kräusslich HG; Hobza P; Král V; Konvalinka J
J Med Chem; 2009 Nov; 52(22):7132-41. PubMed ID: 19874035
[TBL] [Abstract][Full Text] [Related]
30. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.
Aponte JC; Verástegui M; Málaga E; Zimic M; Quiliano M; Vaisberg AJ; Gilman RH; Hammond GB
J Med Chem; 2008 Oct; 51(19):6230-4. PubMed ID: 18798609
[TBL] [Abstract][Full Text] [Related]
32. Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.
Hidaka K; Kimura T; Abdel-Rahman HM; Nguyen JT; McDaniel KF; Kohlbrenner WE; Molla A; Adachi M; Tamada T; Kuroki R; Katsuki N; Tanaka Y; Matsumoto H; Wang J; Hayashi Y; Kempf DJ; Kiso Y
J Med Chem; 2009 Dec; 52(23):7604-17. PubMed ID: 19954246
[TBL] [Abstract][Full Text] [Related]
33. The effects of panduratin A isolated from Kaempferia pandurata on the expression of matrix metalloproteinase-1 and type-1 procollagen in human skin fibroblasts.
Shim JS; Kwon YY; Hwang JK
Planta Med; 2008 Feb; 74(3):239-44. PubMed ID: 18253916
[TBL] [Abstract][Full Text] [Related]
34. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezácová P; Brynda J; Pokorná J; Plesek J; Grüner B; Grantz Sasková K; Václavíková J; Král V; Konvalinka J
J Med Chem; 2008 Aug; 51(15):4839-43. PubMed ID: 18598016
[TBL] [Abstract][Full Text] [Related]
35. Panduratins D-I, novel secondary metabolites from rhizomes of Boesenbergia pandurata.
Win NN; Awale S; Esumi H; Tezuka Y; Kadota S
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):491-6. PubMed ID: 18379096
[TBL] [Abstract][Full Text] [Related]
36. Anti-HIV triterpene acids from Geum japonicum.
Xu HX; Zeng FQ; Wan M; Sim KY
J Nat Prod; 1996 Jul; 59(7):643-5. PubMed ID: 8759159
[TBL] [Abstract][Full Text] [Related]
37. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y
J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195
[TBL] [Abstract][Full Text] [Related]
38. Tripfordines A-C, sesquiterpene pyridine alkaloids from Tripterygium wilfordii, and structure anti-HIV activity relationships of Tripterygium alkaloids.
Horiuch M; Murakami C; Fukamiya N; Yu D; Chen TH; Bastow KF; Zhang DC; Takaishi Y; Imakura Y; Lee KH
J Nat Prod; 2006 Sep; 69(9):1271-4. PubMed ID: 16989518
[TBL] [Abstract][Full Text] [Related]
39. A fast and robust 19F NMR-based method for finding new HIV-1 protease inhibitors.
Frutos S; Tarrago T; Giralt E
Bioorg Med Chem Lett; 2006 May; 16(10):2677-81. PubMed ID: 16517158
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of dammarane-type triterpene derivatives and their ability to inhibit HIV and HCV proteases.
Wei Y; Ma CM; Hattori M
Bioorg Med Chem; 2009 Apr; 17(8):3003-10. PubMed ID: 19339186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
